$23.35
1.18% day before yesterday
Nasdaq, Dec 26, 10:00 pm CET

STAAR Surgical Company Stock price

$23.35
-2.68 10.30% 1M
+6.52 38.74% 6M
-0.94 3.87% YTD
-1.25 5.08% 1Y
-25.04 51.75% 3Y
-57.21 71.02% 5Y
+16.20 226.57% 10Y
+14.84 174.38% 20Y
Nasdaq, Closing price Fri, Dec 26 2025
-0.28 1.18%

New AI Insights on STAAR Surgical Company Insights AI Insights on STAAR Surgical Company

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$1.2b
Enterprise Value
$968.8m
Net debt
positive
Cash
$192.7m
Shares outstanding
49.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
5.0 | 4.4
EV/Sales
4.2 | 3.7
EV/FCF
negative
P/B
3.3
Financial Health
Equity Ratio
78.0%
Return on Equity
-5.1%
ROCE
-15.9%
ROIC
-28.3%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$230.6m | $262.6m
EBITDA
$-54.2m | $4.8m
EBIT
$-62.9m | $-68.8m
Net Income
$-96.4m | $-60.5m
Free Cash Flow
$-39.5m
Growth (TTM | estimate)
Revenue
-32.4% | -16.4%
EBITDA
-272.5% | 172.1%
EBIT
-344.8% | -529.9%
Net Income
-542.5% | -199.4%
Free Cash Flow
-250.3%
Margin (TTM | estimate)
Gross
73.9%
EBITDA
-23.5% | 1.8%
EBIT
-27.3%
Net
-41.8% | -23.0%
Free Cash Flow
-17.2%
More
EPS
$-1.9
FCF per Share
$-0.8
Short interest
17.1%
Employees
1k
Rev per Employee
$270.0k
Show more

Is STAAR Surgical Company a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

STAAR Surgical Company Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a STAAR Surgical Company forecast:

11x Hold
79%
3x Sell
21%

Analyst Opinions

14 Analysts have issued a STAAR Surgical Company forecast:

Hold
79%
Sell
21%

Financial data from STAAR Surgical Company

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
231 231
32% 32%
100%
- Direct Costs 60 60
17% 17%
26%
170 170
37% 37%
74%
- Selling and Administrative Expenses 188 188
1% 1%
82%
- Research and Development Expense 45 45
14% 14%
20%
-54 -54
273% 273%
-24%
- Depreciation and Amortization 8.69 8.69
52% 52%
4%
EBIT (Operating Income) EBIT -63 -63
345% 345%
-27%
Net Profit -96 -96
542% 542%
-42%

In millions USD.

Don't miss a Thing! We will send you all news about STAAR Surgical Company directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

STAAR Surgical Company Stock News

Positive
The Motley Fool
4 days ago
London-based Sand Grove Capital Management acquired 829,123 shares of STAAR Surgical Company in the third quarter. The position was worth about $22.28 million at quarter-end.
Neutral
Business Wire
8 days ago
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which together own 30.2% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today responded to the fourth postponement of STAAR's Special Meeting of Shareholders (the “Special Meeting”) in connection with the proposed acquisition of STAAR by Alcon Inc. ...
Neutral
Business Wire
8 days ago
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) today announced that Alcon (SIX/NYSE: ALC) has exercised its right under the Alcon merger agreement to require STAAR to adjourn its Special Meeting of Stockholders in connection with the Alcon merger agreement (the “Special Meeting”). As a result, the Special Mee...
More STAAR Surgical Company News

Company Profile

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Head office United States
CEO Stephen Farrell
Employees 1,157
Founded 1982
Website www.staar.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today